protein

Bdnf

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Bdnf: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5378Connections
0Hypotheses
2Analyses
50Outgoing
50Incoming

No summary available yet. View on Wiki →

🔬 Protein Info
Gene SymbolSH
Full NameSY5Y Cell Line
Chromosome11p14.1
Protein FamilyNeurotrophin family
Protein TypeLigand
Target ClassLigand
FunctionProtein replacement therapy or small molecule mimetic
Mechanism of ActionProtein replacement therapy or small molecule mimetic
Primary ExpressionSecreted, Synaptic vesicles
DruggabilityLow (0.29)
Clinical StagePhase II
PathwaysAkt, Apoptosis, Autophagy, Cell Cycle, Cholesterol
UniProt IDP23560
NCBI Gene ID627
Ensembl IDENSG00000176697
OMIM113505
GeneCardsSH
Human Protein AtlasSH
Associated DiseasesAddiction, Aging, Als, Alzheimer, Anxiety, Bipolar
Known Drugs/CompoundsDihexa
InteractionsBDNF, AUTOPHAGY, NGF, CHR2, JUN, NEURON
SciDEX TargetView Target Profile (4 clinical trials)
SciDEX HypothesesHippocampal CA3-CA1 synaptic rescue via DHHC2-medi
Hippocampal CA3-CA1 circuit rescue via neurogenesi
Neuroplasticity-Enhanced Learning Hypothesis
KG Connections644 knowledge graph edges
DatabasesGeneCardsHPASTRING
🧬 3D Structure: Bdnf — PDB 1B8M Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

SH-SY5Y Cell Line

cell · 1364 words

cbs-psp-daily-action-plan

therapeutic · 30834 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

Progressive Supranuclear Palsy (PSP)

disease · 12907 words

Corticobasal Syndrome (CBS)

disease · 11374 words

Novel Therapy Index

idea · 10647 words

Pathway Diagram

graph TD
    Bdnf["Bdnf"] -->|"encodes"| Aging["Aging"]
    style Aging fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    Bdnf["Bdnf"] -->|"encodes"| Neurodegeneration["Neurodegeneration"]
    style Neurodegeneration fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    Bdnf["Bdnf"] -->|"encodes"| Als["Als"]
    style Als fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    Bdnf["Bdnf"] -->|"activates"| Stroke["Stroke"]
    style Stroke fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    Bdnf["Bdnf"] -.->|"inhibits"| Ptsd["Ptsd"]
    style Ptsd fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    Bdnf["Bdnf"] -->|"activates"| Depression["Depression"]
    style Depression fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    Bdnf["Bdnf"] -->|"activates"| Diabetes["Diabetes"]
    style Diabetes fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    ELAVL2["ELAVL2"] -->|"encodes"| Bdnf["Bdnf"]
    style ELAVL2 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
    SNAP29["SNAP29"] -->|"encodes"| Bdnf["Bdnf"]
    style SNAP29 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
    FUS["FUS"] -->|"encodes"| Bdnf["Bdnf"]
    style FUS fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
    TDP_43["TDP-43"] -->|"encodes"| Bdnf["Bdnf"]
    style TDP_43 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
    STX17["STX17"] -->|"encodes"| Bdnf["Bdnf"]
    style STX17 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
    style Bdnf fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold

Outgoing (3504)

TargetRelationTypeStr
Agingencodesdisease0.60
Neurodegenerationencodesdisease0.60
Alsencodesdisease0.60
Alsactivatesdisease0.60
Agingactivatesdisease0.60

Incoming (1874)

SourceRelationTypeStr
ELAVL2encodesgene0.60
SNAP29encodesgene0.60
FUSencodesgene0.60
TDP-43encodesgene0.60
STX17encodesgene0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (2)

Scientific analyses that reference this entity

What are the specific circulating factors in exercise-conditioned plasma that me

neurodegeneration | 2026-04-14 | 2 hypotheses Top: 0.589

Why does PGC-1α overexpression paradoxically increase MPTP toxicity despite enha

neurodegeneration | 2026-04-13 | 0 hypotheses

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found